212 related articles for article (PubMed ID: 27118823)
1. Use of palivizumab with other infection control measures to control respiratory syncytial virus outbreaks in neonatal care units.
Hammoud MS; Al-Taiar A; Raina A; Elsori D; Al-Qabandi S; Al-Essa M
J Trop Pediatr; 2016 Oct; 62(5):409-14. PubMed ID: 27118823
[TBL] [Abstract][Full Text] [Related]
2. Experience with the use of palivizumab together with infection control measures to prevent respiratory syncytial virus outbreaks in neonatal intensive care units.
Kurz H; Herbich K; Janata O; Sterniste W; Bauer K
J Hosp Infect; 2008 Nov; 70(3):246-52. PubMed ID: 18799241
[TBL] [Abstract][Full Text] [Related]
3. Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit.
Abadesso C; Almeida HI; Virella D; Carreiro MH; Machado MC
J Hosp Infect; 2004 Sep; 58(1):38-41. PubMed ID: 15350712
[TBL] [Abstract][Full Text] [Related]
4. Palivizumab prophylaxis during nosocomial outbreaks of respiratory syncytial virus in a neonatal intensive care unit: predicting effectiveness with an artificial neural network model.
Saadah LM; Chedid FD; Sohail MR; Nazzal YM; Al Kaabi MR; Rahmani AY
Pharmacotherapy; 2014 Mar; 34(3):251-9. PubMed ID: 23897635
[TBL] [Abstract][Full Text] [Related]
5. Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction.
O'Connell K; Boo TW; Keady D; Niriain U; O'Donovan D; Commane M; Faherty C; Cormican M
J Hosp Infect; 2011 Apr; 77(4):338-42. PubMed ID: 21330007
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial Respiratory Viral Infection in the Neonatal Intensive Care Unit.
Vain NE
Am J Perinatol; 2020 Sep; 37(S 02):S22-S25. PubMed ID: 32898879
[TBL] [Abstract][Full Text] [Related]
7. Outcome of the Respiratory Syncytial Virus related acute lower respiratory tract infection among hospitalized newborns: a prospective multicenter study.
Alan S; Erdeve O; Cakir U; Akduman H; Zenciroglu A; Akcakus M; Tunc T; Gokmen Z; Ates C; Atasay B; Arsan S;
J Matern Fetal Neonatal Med; 2016; 29(13):2186-93. PubMed ID: 26365531
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus outbreak defined by rapid screening in a neonatal intensive care unit.
Dizdar EA; Aydemir C; Erdeve O; Sari FN; Oguz S; Uras N; Dilmen U
J Hosp Infect; 2010 Aug; 75(4):292-4. PubMed ID: 20299133
[TBL] [Abstract][Full Text] [Related]
9. The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit.
Cox RA; Rao P; Brandon-Cox C
J Hosp Infect; 2001 Jul; 48(3):186-92. PubMed ID: 11439005
[TBL] [Abstract][Full Text] [Related]
10. [CONTROLLING AN OUTBREAK OF RESPIRATORY SYNCYTIAL VIRUS (RSV AMONG NICU PATIENTS AND THE MEDICAL TEAM].
Marans R; Eventov-Friedman S; Cohen E; Schwartz C; Averbukh D; Bar-Oz B
Harefuah; 2016 Jan; 155(1):20-3, 68. PubMed ID: 27012069
[TBL] [Abstract][Full Text] [Related]
11. Medical and economic impact of a respiratory syncytial virus outbreak in a neonatal intensive care unit.
Halasa NB; Williams JV; Wilson GJ; Walsh WF; Schaffner W; Wright PF
Pediatr Infect Dis J; 2005 Dec; 24(12):1040-4. PubMed ID: 16371862
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory syncytial virus outbreak in a tertiary hospital Neonatal Intensive Care Unit].
Moreno Parejo C; Morillo García A; Lozano Domínguez C; Carreño Ochoa C; Aznar Martín J; Conde Herrera M
An Pediatr (Barc); 2016 Sep; 85(3):119-27. PubMed ID: 26776167
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases.
Kilani RA
J Trop Pediatr; 2002 Apr; 48(2):118-22. PubMed ID: 12022427
[TBL] [Abstract][Full Text] [Related]
14. Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab.
Kassis C; Champlin RE; Hachem RY; Hosing C; Tarrand JJ; Perego CA; Neumann JL; Raad II; Chemaly RF
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1265-71. PubMed ID: 20304082
[TBL] [Abstract][Full Text] [Related]
15. Nosocomial respiratory syncytial virus infections in the palivizumab-prophylaxis era with implications regarding high-risk infants.
Ashkenazi-Hoffnung L; Dotan M; Livni G; Amir J; Bilavsky E
Am J Infect Control; 2014 Sep; 42(9):991-5. PubMed ID: 25179332
[TBL] [Abstract][Full Text] [Related]
16. Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants.
Pedraz C; Carbonell-Estrany X; Figueras-Aloy J; Quero J;
Pediatr Infect Dis J; 2003 Sep; 22(9):823-7. PubMed ID: 14506376
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Palivizumab against Respiratory Syncytial Virus: Cohort and Case Series Analysis.
Moore HC; de Klerk N; Richmond PC; Fathima P; Xu R; Keil AD; Snelling TL; Strunk T
J Pediatr; 2019 Nov; 214():121-127.e1. PubMed ID: 31378522
[TBL] [Abstract][Full Text] [Related]
18. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
19. Adherence to Palivizumab for Respiratory Syncytial Virus Prevention in the Canadian Registry of Palivizumab.
Chan P; Li A; Paes B; Abraha H; Mitchell I; Lanctôt KL;
Pediatr Infect Dis J; 2015 Dec; 34(12):e290-7. PubMed ID: 26780032
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey.
Oncel MY; Mutlu B; Kavurt S; Baş AY; Demirel N; Akyol M; Erdeve O; Dilmen U
Turk J Pediatr; 2012; 54(4):344-51. PubMed ID: 23692714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
